You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Nedaplatin

Showing 1 - 25 of 88
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Esophageal Squamous Cell Carcinoma Trial (Fruquintinib Combined With Camrelizumab, Paclitaxel Liposome and Nedaplatin)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • Fruquintinib Combined With Camrelizumab, Paclitaxel Liposome and Nedaplatin
  • (no location specified)
Aug 17, 2023

NSCLC Trial in Guangzhou (split-course radiotherapy, concurrent chemo)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • split-course radiotherapy
  • concurrent chemotherapy
  • Guangzhou, China
    Sun Yat-sen University
Nov 25, 2022

Hypopharyngeal Cancer Trial (Cisplatin/Nedaplatin, albumin paclitaxel)

Not yet recruiting
  • Hypopharyngeal Cancer
  • Cisplatin/Nedaplatin, albumin paclitaxel
  • (no location specified)
May 5, 2023

Carcinoma,Non-Small-Cell Lung Trial in Guangzhou (cisplatin and pemetrexed, nedaplatin+pemetrexed)

Recruiting
  • Carcinoma，Non-Small-Cell Lung
  • Guangzhou, Guangdong, China
    Sun Yat-sen University of cancer center
Feb 8, 2022

Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma

Recruiting
  • Esophageal Squamous Cell Carcinoma
    • Shijiazhuang, Hebei, China
      Department of Thoracic Surgery, Fourth Hospital of Hebei Medical
    Oct 25, 2023

    Esophageal Carcinoma, Neoadjuvant Immunotherapy Trial in Beijing (PD-1 blockade, Albumin paclitaxel, Carboplatin/Nedaplatin)

    Recruiting
    • Esophageal Carcinoma
    • Neoadjuvant Immunotherapy
    • PD-1 blockade
    • +2 more
    • Beijing, Beijing, China
      Qin li
    Mar 8, 2023

    Esophageal Squamous Cell Carcinoma Trial in Chongqing (Tislelizumab)

    Not yet recruiting
    • Esophageal Squamous Cell Carcinoma
    • Chongqing, Chongqing, China
      Army Medical Center of the People's Liberation Army
    May 26, 2023

    Head and Neck Squamous Carcinoma Trial in Guiyang (Nedaplatin, Cisplatin)

    Not yet recruiting
    • Head and Neck Squamous Carcinoma
    • Guiyang, Guizhou, China
      The Affiliated Cancer Hospital of Guizhou Medical University
    Sep 1, 2021

    Head and Neck Squamous Cell Carcinoma, Neoadjuvant Therapy, Pembrolizumab Trial in Beijing (Pembrolizumab, Cisplatin,

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • +2 more
    • Beijing, Beijing, China
      Beijing Tongren Hospital
    Oct 26, 2023

    Head and Neck Squamous Cell Carcinoma Trial (Nimotuzumab Combined With Neoadjuvant Chemotherapy)

    Not yet recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Nimotuzumab Combined With Neoadjuvant Chemotherapy
    • (no location specified)
    Jun 29, 2022

    Immunotherapy Esophagus Cancer Trial (Tislelizumab, Albumin paclitaxel, Nedaplatin)

    Not yet recruiting
    • Immunotherapy Esophagus Cancer
    • (no location specified)
    Aug 24, 2022

    Nasopharyngeal Carcinoma Trial in Guangzhou (Docetaxel, nedaplatin, fluorouracil, Docetaxel, cisplatin, fluorouracil,

    Recruiting
    • Nasopharyngeal Carcinoma
    • Docetaxel, nedaplatin, fluorouracil
    • +4 more
    • Guangzhou, Guangdong, China
      Department of radiotherapy(Section 5),Affiliated Cancer Hospital
    Apr 1, 2021

    Advanced Non-squamous Non-Small-Cell Lung Cancer Trial in Jinan (Sintilimab)

    Recruiting
    • Advanced Non-squamous Non-Small-Cell Lung Cancer
    • Jinan, Shandong, China
      The First Affiliated Hospital of Shandong First Medical Universi
    Dec 4, 2022

    Esophageal Squamous Cell Carcinoma Trial in Guangzhou (Toripalimab, Paclitaxel-albumin, Nedaplatin)

    Recruiting
    • Esophageal Squamous Cell Carcinoma
    • Guangzhou, Guangdong, China
      Sun yat-sen University Cancer Center
    Oct 25, 2022

    Locally Advanced Esophageal Squamous Cell Carcinoma Trial in Zhengzhou (SHR-1210+docetaxel+nedaplatin, SHR-1210+Apatinib)

    Recruiting
    • Locally Advanced Esophageal Squamous Cell Carcinoma
    • Zhengzhou, Henan, China
      The First Affiliated Hospital of Zhengzhou University
    Feb 16, 2022

    Locally Advanced Esophageal Squamous Cell Carcinoma Trial in Zhengzhou (Toripalimab+Nedaplatin+Albumin Paclitaxel)

    Not yet recruiting
    • Locally Advanced Esophageal Squamous Cell Carcinoma
    • Toripalimab+Nedaplatin+Albumin Paclitaxel
    • Zhengzhou, Hennan, China
      The First Affiliated Hospital of Zhengzhou University
    Aug 19, 2021

    NSCLC Trial in Guangzhou (chest radiation(IMRT), Concurrent chemo twice a week, Concurrent chemo once a week)

    Recruiting
    • Non-small Cell Lung Cancer
    • chest radiation(IMRT)
    • +2 more
    • Guangzhou, China
      Sun Yat-sen University
    Aug 20, 2020

    Esophageal Squamous Cell Carcinoma Trial in Guangzhou (Docetaxel, Nedaplatin, chest radiation)

    Completed
    • Esophageal Squamous Cell Carcinoma
    • Guangzhou, Guangdong, China
      Hui Liu
    May 13, 2020

    Anti-emetic Drug Upon Combination Chemotherapy for Non-small

    Completed
    • Non-small Cell Lung Cancer
    • Otsu, Shiga, Japan
      Shiga University of Medical Science Hospital
    Aug 28, 2020

    Esophageal Squamous Cell Carcinoma Trial in Beijing (SHR-1210, Apatinib, Irinotecan Injection)

    Unknown status
    • Esophageal Squamous Cell Carcinoma
    • Beijing, China
      Jing Huang
    Feb 9, 2020

    Esophageal Squamous Cell Carcinoma Trial in Guangzhou (Paclitaxel+Nedaplatin+Endostar)

    Unknown status
    • Esophageal Squamous Cell Carcinoma
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Oct 27, 2019

    Recurrent and Metastatic Nasopharyngeal Carcinoma Trial (nedaplatin and gemcitabine)

    Terminated
    • Recurrent and Metastatic Nasopharyngeal Carcinoma
    • nedaplatin and gemcitabine
    • (no location specified)
    Sep 4, 2019

    Esophageal Squamous Carcinoma, HER-2 Protein Overexpression Trial (RC48+PD-1+platinum-based)

    Not yet recruiting
    • Esophageal Squamous Carcinoma
    • HER-2 Protein Overexpression
    • (no location specified)
    Sep 24, 2023

    Thoracic Esophageal Squamous Cell Carcinoma Trial in GuangZhou (adjuvant chemo, standard two field Lymphadenectomy, Total two

    Completed
    • Thoracic Esophageal Squamous Cell Carcinoma
    • adjuvant chemotherapy
    • +3 more
    • GuangZhou, Guangdong, China
      Sun Yat-sen Uniersity Cancer Center
    Mar 30, 2022

    Esophageal Tumors, Esophageal Cancer Trial in Beijing (Adjuvant Chemoradiation, Adjuvant Radiation, Paclitaxel)

    Active, not recruiting
    • Esophageal Neoplasms
    • Esophageal Cancer
    • Adjuvant Chemoradiation
    • +3 more
    • Beijing, Beijing, China
      Cancer Institute and Hospital, Chinese Academy of Medical Scienc
    Apr 2, 2020